1-[5-(2,3-dichlorophenyl)sulfanyl-6-methyl-1H-imidazo[4,5-b]pyrazin-2-yl]-4-methylpiperidin-4-amine
C18H20Cl2N6S — CID 155796661
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[5-(2,3-dichlorophenyl)sulfanyl-6-methyl-1H-imidazo[4,5-b]pyrazin-2-yl]-4-methylpiperidin-4-amine
1-[5-(2,3-dichlorophenyl)sulfanyl-6-methyl-1H-imidazo[4,5-b]pyrazin-2-yl]-4-methylpiperidin-4-amine (PubChem CID 155796661) has the molecular formula C18H20Cl2N6S and a molecular weight of 423.37 g/mol. Its IUPAC name is 1-[5-(2,3-dichlorophenyl)sulfanyl-6-methyl-1H-imidazo[4,5-b]pyrazin-2-yl]-4-methylpiperidin-4-amine.
Molecular Properties
| Compound Name | 1-[5-(2,3-dichlorophenyl)sulfanyl-6-methyl-1H-imidazo[4,5-b]pyrazin-2-yl]-4-methylpiperidin-4-amine |
|---|---|
| PubChem CID | 155796661 |
| Molecular Formula | C18H20Cl2N6S |
| Molecular Weight | 423.37 g/mol |
| Exact Mass | 422.08 |
| IUPAC Name | 1-[5-(2,3-dichlorophenyl)sulfanyl-6-methyl-1H-imidazo[4,5-b]pyrazin-2-yl]-4-methylpiperidin-4-amine |
| SMILES | Cc1nc2[nH]c(N3CCC(C)(N)CC3)nc2nc1Sc1cccc(Cl)c1Cl |
| InChI | InChI=1S/C18H20Cl2N6S/c1-10-16(27-12-5-3-4-11(19)13(12)20)23-15-14(22-10)24-17(25-15)26-8-6-18(2,21)7-9-26/h3-5H,6-9,21H2,1-2H3,(H,22,23,24,25) |
| InChIKey | LBLCHLWPLSITLN-UHFFFAOYSA-N |
| XLogP | 4.44 |
| TPSA | 83.72 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 423.37 |
| LogP ≤ 5 | 4.44 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155796661 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.